BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 29890815)

  • 21. Pyoderma gangrenosum as a first presentation of inflammatory bowel disease.
    Shahid S; Myszor M; De Silva A
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25385558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pyoderma gangrenosum: a report of 15 cases and review of the literature].
    Suárez-Pérez JA; Herrera-Acosta E; López-Navarro N; Vilchez-Márquez F; Prieto JD; Bosch RJ; Herrera E
    Actas Dermosifiliogr; 2012 Mar; 103(2):120-6. PubMed ID: 21782147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyoderma Gangrenosum - a Challenging Diagnostic Approach.
    Psoma O; Loli A; Dimos G; Liappis I; Giotis D; Panagiotopoulos V; Konstantinidis C
    Maedica (Bucur); 2023 Sep; 18(3):528-533. PubMed ID: 38023744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Penile ulcerative pyoderma gangrenosum: A rare entity.
    Patel JK; Pillai DS; Bodar P; Nair PA
    Indian J Sex Transm Dis AIDS; 2023; 44(1):77-79. PubMed ID: 37457536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Upadacitinib Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis for Ulcerative Colitis Achieved Ulcer Healing for Pyoderma Gangrenosum.
    Tanida S; Kubo R; Yoshii S; Takahama T; Sasoh S; Kubota Y; Ban T; Ando T; Nakamura M; Joh T
    J Clin Med Res; 2023 Dec; 15(10-11):446-455. PubMed ID: 38189038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
    Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
    Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytapheresis for pyoderma gangrenosum associated with inflammatory bowel disease: A review of current status.
    Tominaga K; Kamimura K; Sato H; Ko M; Kawata Y; Mizusawa T; Yokoyama J; Terai S
    World J Clin Cases; 2020 Jun; 8(11):2092-2101. PubMed ID: 32548138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic recurrent multifocal osteomyelitis preceding pyoderma gangrenosum and occult ulcerative colitis in a pediatric patient.
    Omidi CJ; Siegfried EC
    Pediatr Dermatol; 1998; 15(6):435-8. PubMed ID: 9875964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimating the Odds of Ulcerative Colitis-Associated Pyoderma Gangrenosum: A Population-Based Case-Control Study.
    Kridin K; Damiani G; Ludwig RJ; Tzur Bitan D; Cohen AD
    Dermatology; 2021; 237(3):323-329. PubMed ID: 33647909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disseminated refractory pyoderma gangraenosum during an ulcerative colitis flare. Treatment with infliximab.
    Zampeli VA; Lippert U; Nikolakis G; Makrantonaki E; Tzellos TG; Krause U; Zouboulis CC
    J Dermatol Case Rep; 2015 Sep; 9(3):62-6. PubMed ID: 26512301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.
    Ueda M; Katoh M; Tanizaki H; Tanioka M; Matsumura Y; Miyachi Y
    Dermatol Online J; 2012 Jan; 18(1):12. PubMed ID: 22301049
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Paraneoplastic Pyoderma Gangrenosum Associated with Rectal Adenocarcinoma.
    You HR; Ju JK; Yun SJ; Lee JB; Kim SJ; Won YH; Lee SC
    Ann Dermatol; 2018 Feb; 30(1):79-82. PubMed ID: 29386837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutaneous manifestations in inflammatory bowel disease.
    Tromm A; May D; Almus E; Voigt E; Greving I; Schwegler U; Griga T
    Z Gastroenterol; 2001 Feb; 39(2):137-44. PubMed ID: 11253504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concomitant manifestation of pyoderma gangrenosum and colorectal carcinoma.
    Bunte C; Popp-Habeler J; Mischer P; Tuppy H; Haidenthaler A; Knoflach P; Kirchgatterer A
    Scand J Gastroenterol; 2008; 43(6):756-8. PubMed ID: 18569994
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pyoderma gangrenosum: a commonly overlooked ulcerative condition.
    Tay DZ; Tan KW; Tay YK
    J Family Med Prim Care; 2014; 3(4):374-8. PubMed ID: 25657946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Simultaneous onset of ulcerative colitis and disseminated pyoderma gangrenosum.
    Neesse A; Michl P; Kunsch S; Ellenrieder V; Gress TM; Steinkamp M
    Case Rep Gastroenterol; 2007 Oct; 1(1):110-5. PubMed ID: 21487555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incisional pyoderma gangrenosum after caesarean section: Two case reports.
    Murata T; Kyozuka H; Fukuda T; Hiraiwa T; Yamaguchi A; Fujimori K
    Case Rep Womens Health; 2019 Jul; 23():e00128. PubMed ID: 31431888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pyoderma gangrenosum with an underlying ulcerative colitis associated with bone tuberculosis.
    Patvekar MA; Virmani NC
    Indian Dermatol Online J; 2013 Jan; 4(1):43-6. PubMed ID: 23440150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nasal mucosa pyoderma vegetans associated with ulcerative colitis: A case report.
    Yu SX; Cheng XK; Li B; Hao JH
    World J Clin Cases; 2020 Oct; 8(20):4953-4957. PubMed ID: 33195666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.